FRP Advisory Group plc (AIM:FRP)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 288.71M |
| Revenue (ttm) | 161.70M |
| Net Income (ttm) | 22.90M |
| Shares Out | 241.60M |
| EPS (ttm) | 0.09 |
| PE Ratio | 13.21 |
| Forward PE | 10.35 |
| Dividend | 0.05 (4.58%) |
| Ex-Dividend Date | May 14, 2026 |
| Volume | 222,938 |
| Average Volume | 811,129 |
| Open | 118.98 |
| Previous Close | 118.00 |
| Day's Range | 117.75 - 119.97 |
| 52-Week Range | 103.00 - 151.00 |
| Beta | 0.27 |
| RSI | 55.21 |
| Earnings Date | Feb 13, 2026 |
About FRP Advisory Group
FRP Advisory Group plc, together with its subsidiaries, provides business advisory services to companies, lenders, investors, individuals, and other stakeholders in the United Kingdom. The company’s corporate finance advisory services include mergers and acquisitions (M&A), strategic advisory and valuations, capital raising, special situations M&A, partial exits, and financial due diligence; and debt advisory services comprise asset based lending, raising and refinancing debt, debt amendments and extensions, restructuring debt, and corporate an... [Read more]
Financial Performance
In fiscal year 2025, FRP Advisory Group's revenue was 152.20 million, an increase of 18.72% compared to the previous year's 128.20 million. Earnings were 22.50 million, an increase of 2.27%.
Financial StatementsNews
Denby appoints administrators in 'necessary step'
The 217-year-old firm says it appointed FRP Advisory as administrators on Tuesday.
FRP Advisory Group a bargain in a booming market
FRP Advisory Group's past and future growth isnt reflected in the companys valuation
FRP Advisory Group Earnings Call Transcript: H2 2025
Revenue grew 19% year-over-year, with 11% organic growth and five acquisitions driving expansion. Adjusted EBITDA margin reached 27%, and the business maintained strong cash conversion and a robust balance sheet. Outlook for FY 2026 is positive, with a healthy M&A pipeline and continued focus on sustainable growth.
FRP Advisory Group Earnings Call Transcript: H1 2025
Strong H1 FY2025 results featured 32% revenue growth and 44% higher Adjusted EBITDA, driven by organic expansion and four strategic acquisitions. The business remains confident in meeting full-year expectations, with robust pipelines across all service lines.
Cancer test firm Oncologica looking to raise cash
Cambridge-based Oncologica has hired consultants FRP Advisory to tap potential investors for £6 million.
FRP Advisory Group Earnings Call Transcript: H2 2024
Revenue grew 23% year-over-year, with 19% organic growth and adjusted EBITDA up 37%. Market share in administration reached 16%, supported by acquisitions and team expansion. Outlook remains positive with a strong M&A pipeline and continued investment in growth.